Published in Proc Natl Acad Sci U S A on August 15, 1991
Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Immunology (1993) 1.13
Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology (1994) 1.10
Differential geometric analysis of alterations in MH α-helices. J Comput Chem (2013) 0.85
Staphylococcus-mediated T-cell activation and spontaneous natural killer cell activity in the absence of major histocompatibility complex class II molecules. Infect Immun (1993) 0.84
Staphylococcal enterotoxins bind H-2Db molecules on macrophages. Proc Natl Acad Sci U S A (1995) 0.80
Construction and characterization of a novel fusion protein MG7-scFv/SEB against gastric cancer. J Biomed Biotechnol (2010) 0.80
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (1987) 12.43
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (1988) 5.99
Superantigens interact with MHC class II molecules outside of the antigen groove. Cell (1990) 3.20
Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01
HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med (1990) 2.30
Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol (1991) 1.50
Solid-phase peptide synthesis using mild base cleavage of N alpha-fluorenylmethyloxycarbonylamino acids, exemplified by a synthesis of dihydrosomatostatin. Int J Pept Protein Res (1978) 1.43
The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature (1990) 1.34
Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1991) 1.09
The I-A beta b region (65-85) is a binding site for the superantigen, staphylococcal enterotoxin A. Biochem Biophys Res Commun (1990) 1.04
Site of nonrestrictive binding of SEA to class II MHC antigens. Int Arch Allergy Appl Immunol (1990) 0.88
Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med (1982) 5.33
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol (1983) 4.38
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol (1981) 4.04
Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01
Staphylococcal enterotoxin B: solid-phase radioimmunoassay. Appl Microbiol (1971) 2.69
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature (1984) 2.18
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest (1984) 2.00
Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99
Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation. J Bacteriol (1966) 1.96
The use of a wate-soluble carbodiimide as a coupling reagent in the passive hemagglutination test. J Immunol (1966) 1.94
Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect Immun (1979) 1.89
The effect of staphylococcal enterotoxins on the primary in vitro immune response. J Immunol (1975) 1.88
Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85
Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol (1982) 1.79
Staphylococcal enterotoxins A and B: solid-phase radioimmunoassay in food. Appl Microbiol (1973) 1.66
Large-scale production and partial purification of mouse immune interferon. Infect Immun (1979) 1.57
Antigenic cross-reactivity of staphylococcal enterotoxins. Infect Immun (1972) 1.53
Long-term mortality profile of heavily-exposed lead smelter workers. J Occup Med (1982) 1.53
Classification of interferons with antibody to immune interferon. Cell Immunol (1980) 1.49
The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol (1983) 1.46
Stability of 125I-labeled staphylococcal enterotoxins in solid-phase radioimmunoassay. Appl Microbiol (1975) 1.45
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci U S A (1982) 1.44
Simple Eye Tests in a Pediatrician's Office: Their Value. Cal West Med (1937) 1.36
Staphylococcal enterotoxin microbial superantigens. FASEB J (1991) 1.34
Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures. J Immunol (1982) 1.32
Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol (1993) 1.27
Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. J Immunol (1989) 1.25
Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23
Enterotoxin B: serological assay in cultures by passive hemagglutination. Appl Microbiol (1967) 1.23
The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol (1976) 1.21
Leukotrienes: positive signals for regulation of gamma-interferon production. J Immunol (1984) 1.13
Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA. J Immunol (1992) 1.13
Differentiation of the immunosuppressive and antiviral effects of interferon. Cell Immunol (1978) 1.13
Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol (1982) 1.12
Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1991) 1.09
So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine (2001) 1.08
Interleukin 2 regulation of mitogen induction of immune interferon (IFN gamma) in spleen cells and thymocytes. Cell Immunol (1982) 1.06
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Cancer Res (2000) 1.06
Immune interferon induction by T-cell mitogens involves different T-cell subpopulations. Cell Immunol (1979) 1.06
Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol (1984) 1.05
A qualitative comparison of paper flowsheets vs a computer-based clinical information system. Chest (1991) 1.04
Running elevates plasma beta-endorphin immunoreactivity and ACTH in untrained human subjects. Proc Soc Exp Biol Med (1981) 1.04
The I-A beta b region (65-85) is a binding site for the superantigen, staphylococcal enterotoxin A. Biochem Biophys Res Commun (1990) 1.04
Induction of an inhibitor of interferon action in a mouse lymphokine preparation. Infect Immun (1979) 1.03
Interleukin 2-mediated events in gamma-interferon production are calcium dependent at more than one site. J Immunol (1985) 1.02
Superantigens in human disease. Sci Am (1992) 1.01
Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma. J Interferon Cytokine Res (2000) 1.00
Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A (1993) 1.00
Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol (1993) 1.00
Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem Biophys Res Commun (1988) 1.00
Superantigens: the good, the bad, and the ugly. Exp Biol Med (Maywood) (2001) 0.99
Enhanced contrast in electron microscopy of unstained biological material. 3. In-focus phase contrast of large objects. J Microsc (1973) 0.99
Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res (1991) 0.99
Phorbol ester replacement of helper cell and interleukin 2 requirements in gamma interferon production. Infect Immun (1982) 0.98
Staphylococcal enterotoxin C: solid-phase radioimmunoassay. Appl Microbiol (1975) 0.98
Immune-type interferon-induced transfer of viral resistance. J Immunol (1979) 0.97
Interferon: effects on the immune response and the mechanism of activation of the cellular response. CRC Crit Rev Biochem (1976) 0.96
Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc Natl Acad Sci U S A (1995) 0.96
The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J Cell Sci (2000) 0.96
Interferon inhibition of the primary in vitro antibody response to a thymus-independent antigen. Cell Immunol (1975) 0.95
Cellular regulation of gamma interferon production: Lyt phenotype of the suppressor cell. Infect Immun (1982) 0.95
IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene (1997) 0.94
The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence. J Biol Chem (1999) 0.94
Binding of IFN gamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function. Biochem Biophys Res Commun (1994) 0.93
Clinical evaluation of a computer-based patient monitoring and data management system. Heart Lung (1991) 0.93
T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc Natl Acad Sci U S A (1992) 0.93
Identification of IFN-gamma receptor binding sites for JAK2 and enhancement of binding by IFN-gamma and its C-terminal peptide IFN-gamma(95-133). J Immunol (1995) 0.92
The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol (1995) 0.92
Modulation of disease by superantigens. Curr Opin Immunol (1998) 0.92
Bacterial and retroviral superantigens share a common binding region on class II MHC antigens. Nature (1993) 0.92
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon. Proc Natl Acad Sci U S A (1985) 0.91
Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence. J Interferon Cytokine Res (2001) 0.91
Possibility of a phase contrast electron microscope. Appl Opt (1972) 0.91
Structural requirements for agonist activity of a murine interferon-gamma peptide. J Interferon Cytokine Res (1996) 0.90
Staphylococcus aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells. J Immunol (1983) 0.90
IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. J Interferon Cytokine Res (1999) 0.90
Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach. J Immunol (1986) 0.90
Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase. J Interferon Cytokine Res (2000) 0.89
IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential. Int J Cancer (1998) 0.89
Vasopressin replacement of interleukin 2 requirement in gamma interferon production: lymphokine activity of a neuroendocrine hormone. J Immunol (1982) 0.88
The role of interferon in virus infections and antibody formation. Pathobiol Annu (1978) 0.88
The induction of at least two distinct types of interferon in mouse spleen cell cultures by Corynebacterium parvum. Cell Immunol (1981) 0.88
Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci U S A (1986) 0.88
Site of nonrestrictive binding of SEA to class II MHC antigens. Int Arch Allergy Appl Immunol (1990) 0.88
Carbodiimide hemagglutination. A study of some of the variables of the coupling reaction. Int Arch Allergy Appl Immunol (1968) 0.87
Second messenger role of arachidonic acid and its metabolites in interferon-gamma production. J Immunol (1986) 0.87
Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon. Biochem Biophys Res Commun (1983) 0.86
Strontium deposits in isolated plant mitochondria. Exp Cell Res (1973) 0.86
Lipopolysaccharide and polyribonucleotide activation of macrophages: implications for a natural triggering signal in tumor cell killing. Biochem Biophys Res Commun (1985) 0.86
The N-terminus and C-terminus of IFN-gamma are binding domains for cloned soluble IFN-gamma receptor. J Immunol (1992) 0.86
Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. Blood (1999) 0.86
Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1). J Neurooncol (2000) 0.85
Interferon immunosuppression: mediation by a suppressor factor. Infect Immun (1980) 0.85